155 related articles for article (PubMed ID: 6230541)
1. The measurement of abnormal movement: methods developed for Huntington's disease.
Folstein SE; Jensen B; Leigh RJ; Folstein MF
Neurobehav Toxicol Teratol; 1983; 5(6):605-9. PubMed ID: 6230541
[TBL] [Abstract][Full Text] [Related]
2. Alterations in voluntary movement execution in Huntington's disease are related to the dominant motor system: evidence from event-related potentials.
Beste C; Konrad C; Saft C; Ukas T; Andrich J; Pfleiderer B; Hausmann M; Falkenstein M
Exp Neurol; 2009 Mar; 216(1):148-57. PubMed ID: 19111540
[TBL] [Abstract][Full Text] [Related]
3. Objective assessment of motor slowness in Huntington's disease: clinical correlates and 2-year follow-up.
van Vugt JP; Piet KK; Vink LJ; Siesling S; Zwinderman AH; Middelkoop HA; Roos RA
Mov Disord; 2004 Mar; 19(3):285-97. PubMed ID: 15022182
[TBL] [Abstract][Full Text] [Related]
4. Predictors of neuropathological severity in 100 patients with Huntington's disease.
Rosenblatt A; Abbott MH; Gourley LM; Troncoso JC; Margolis RL; Brandt J; Ross CA
Ann Neurol; 2003 Oct; 54(4):488-93. PubMed ID: 14520661
[TBL] [Abstract][Full Text] [Related]
5. A shortened version of the motor section of the Unified Huntington's Disease Rating Scale.
Siesling S; Zwinderman AH; van Vugt JP; Kieburtz K; Roos RA
Mov Disord; 1997 Mar; 12(2):229-34. PubMed ID: 9087982
[TBL] [Abstract][Full Text] [Related]
6. Quantification of chorea in Huntington's disease by power spectral analysis.
Weitzman DO; Rosfnfeld C; Korenyl C; Whittier JR
Dis Nerv Syst; 1976 May; 37(5):264-8. PubMed ID: 131027
[TBL] [Abstract][Full Text] [Related]
7. Reliance on advance information and movement sequencing in Huntington's disease.
Georgiou N; Bradshaw JL; Phillips JG; Chiu E; Bradshaw JA
Mov Disord; 1995 Jul; 10(4):472-81. PubMed ID: 7565829
[TBL] [Abstract][Full Text] [Related]
8. Unified Huntington's disease rating scale: clinical practice and a critical approach.
Klempír J; Klempírova O; Spacková N; Zidovská J; Roth J
Funct Neurol; 2006; 21(4):217-21. PubMed ID: 17367582
[TBL] [Abstract][Full Text] [Related]
9. Choreas, hereditary and other ataxias, tics, myoclonus, and other movement disorders.
Tolosa E; Berciano J
Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):358-68. PubMed ID: 8507906
[TBL] [Abstract][Full Text] [Related]
10. Interrater agreement in the assessment of motor manifestations of Huntington's disease.
Hogarth P; Kayson E; Kieburtz K; Marder K; Oakes D; Rosas D; Shoulson I; Wexler NS; Young AB; Zhao H
Mov Disord; 2005 Mar; 20(3):293-7. PubMed ID: 15584032
[TBL] [Abstract][Full Text] [Related]
11. Subtle involuntary movements are not reliable indicators of incipient Huntington's disease.
de Boo G; Tibben A; Hermans J; Maat A; Roos RA
Mov Disord; 1998 Jan; 13(1):96-9. PubMed ID: 9452333
[TBL] [Abstract][Full Text] [Related]
12. Short-term variability in amplitude and motor topography of whole-body involuntary movements in Parkinson's disease dyskinesias and in Huntington's chorea.
Fenney A; Jog MS; Duval C
Clin Neurol Neurosurg; 2008 Feb; 110(2):160-7. PubMed ID: 18063471
[TBL] [Abstract][Full Text] [Related]
13. Abnormalities of the contingent negative variation in Huntington's disease: correlations with clinical features.
de Tommaso M; Difruscolo O; Sciruicchio V; Specchio N; Livrea P
J Neurol Sci; 2007 Mar; 254(1-2):84-9. PubMed ID: 17300807
[TBL] [Abstract][Full Text] [Related]
14. Unified Huntington's disease rating scale: a follow up.
Siesling S; van Vugt JP; Zwinderman KA; Kieburtz K; Roos RA
Mov Disord; 1998 Nov; 13(6):915-9. PubMed ID: 9827615
[TBL] [Abstract][Full Text] [Related]
15. Assessment of simple movements reflects impairment in Huntington's disease.
Saft C; Andrich J; Meisel NM; Przuntek H; Müller T
Mov Disord; 2006 Aug; 21(8):1208-12. PubMed ID: 16700032
[TBL] [Abstract][Full Text] [Related]
16. Complex movement behaviour and progression of Huntington's disease.
Andrich J; Saft C; Ostholt N; Müller T
Neurosci Lett; 2007 Apr; 416(3):272-4. PubMed ID: 17321683
[TBL] [Abstract][Full Text] [Related]
17. Motor timing variability increases in preclinical Huntington's disease patients as estimated onset of motor symptoms approaches.
Hinton SC; Paulsen JS; Hoffmann RG; Reynolds NC; Zimbelman JL; Rao SM
J Int Neuropsychol Soc; 2007 May; 13(3):539-43. PubMed ID: 17445303
[TBL] [Abstract][Full Text] [Related]
18. Saccades in presymptomatic and early stages of Huntington disease.
Blekher T; Johnson SA; Marshall J; White K; Hui S; Weaver M; Gray J; Yee R; Stout JC; Beristain X; Wojcieszek J; Foroud T
Neurology; 2006 Aug; 67(3):394-9. PubMed ID: 16855205
[TBL] [Abstract][Full Text] [Related]
19. [Chorea and Huntington's disease].
Dürr A
Rev Prat; 1997 May; 47(10):1083-7. PubMed ID: 9208671
[TBL] [Abstract][Full Text] [Related]
20. Short-term continuous infusion of apomorphine hydrochloride for treatment of Huntington's chorea: A double blind, randomized cross-over trial.
Vitale C; Marconi S; Di Maio L; De Michele G; Longo K; Bonavita V; Barone P
Mov Disord; 2007 Dec; 22(16):2359-64. PubMed ID: 17894335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
